Pearla Awad: Liposomal Iron Is Better Tolerated, With Fewer Adverse Effects and Lower Constipation Rates
Pearla Awad, Student Council, Cardiology Society Research Officer at RCSI Medical University of Bahrain, shared on LinkedIn about a recent article she and her colleagues co-authored, published in European Journal of Pediatrics, adding:
”Proud to share our latest publication in the European Journal of Pediatrics:
‘Safety and efficacy of liposomal iron for iron deficiency anemia in pediatric population: a systematic review and meta-analysis of randomized controlled trials.’
In this study, we analyzed data from four randomized controlled trials involving 454 pediatric patients.
We found that liposomal iron is better tolerated, with fewer adverse effects and lower rates of constipation, while delivering comparable, and in some cases greater, hematologic outcomes compared to conventional oral iron.
Have a read.
This project was a great opportunity to explore an evolving therapeutic approach in pediatric hematology and contribute to the growing evidence supporting liposomal iron formulations. Grateful to all co-authors and collaborators for their contributions and teamwork throughout this project.”
Title: Safety and efficacy of liposomal iron for iron deficiency anemia in pediatric population: A systematic review and meta-analysis of randomized controlled trials
Authors: Abdullah M. Alharran, Esraa Yousef Almutairi, Waleed Bader Alazemi, Fatemah Adel Alnejadah, Hasan S Hasan, Layal AlOufan, Asayel M Alsultan, Hala AlOmar, Maryam Alqayem, Joy Maasarani, Aljazi Alohaly, Pearla Awad, Abdullatif Alfehaid

Stay updated on all scientific advances with Hemostasis Today.
-
Sep 18, 2026, 17:48Ronak H. Mistry: Updated ASH Guidelines Bring New Focus to Iron Deficiency
-
Sep 18, 2026, 17:32Hassan Kawtharany: New Ferritin Cutoffs for the Diagnosis of Iron Deficiency With or Without Anemia
-
Sep 18, 2026, 17:20Abhishek G P: GAVE as an Important Cause of Chronic Gastrointestinal Blood Loss
-
Sep 18, 2026, 17:08Irem Karaman Sebin: ASH 2026 Changes a Key Concept in Iron Deficiency
-
Sep 18, 2026, 16:51Adarsh Krishnan Sundara Rajan: Is VTE the Most Underdiagnosed Critical Threat in Modern Healthcare?
-
Sep 18, 2026, 16:19CRISPR and Hemophilia: The Next Frontier of In Vivo Gene Editing
-
Sep 18, 2026, 16:13Christian Irsara: PF4 Immunothrombosis Following Natural Adenovirus Infection
-
Sep 18, 2026, 16:10Leo Nicolai։ The Spleen Emerges as a Key Regulator of Thromboinflammation
-
Sep 18, 2026, 16:05Targeting Factor XI to Reduce Thrombosis Without Compromising Hemostasis – ISTH